- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股处于空头行情中，可能有短期反弹。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有10家主力机构披露2025-12-31报告期持股数据，持仓量总计276.38万股，占流通A股2.01%
- 波段诊断：
-
技术面诊股
诊断结果：4.3技术面打败了23%的股票
技术面评分前10的股票
近期的平均成本为101.34元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为101.34元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"101.34","date":1772528143,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，接近行业平均水平。
[{"date":"2026.03.04","stock":"-3.56","trade":null,"ind":"-0.98"},{"date":"2026.03.03","stock":"-4.04","trade":null,"ind":"-1.43"},{"date":"2026.03.02","stock":"4.95","trade":null,"ind":"0.47"},{"date":"2026.02.27","stock":"-1.04","trade":null,"ind":"0.39"},{"date":"2026.02.26","stock":"1.63","trade":null,"ind":"-0.01"},{"date":"2026.02.25","stock":"0.58","trade":null,"ind":"0.72"},{"date":"2026.02.24","stock":"0.31","trade":null,"ind":"0.87"},{"date":"2026.02.13","stock":"0.60","trade":null,"ind":"-1.26"},{"date":"2026.02.12","stock":"-0.75","trade":null,"ind":"0.05"},{"date":"2026.02.11","stock":"-1.48","trade":null,"ind":"0.09"},{"date":"2026.02.10","stock":"-1.56","trade":null,"ind":"0.13"},{"date":"2026.02.09","stock":"-0.35","trade":null,"ind":"1.41"},{"date":"2026.02.06","stock":"-1.18","trade":null,"ind":"-0.25"},{"date":"2026.02.05","stock":"1.90","trade":null,"ind":"-0.64"},{"date":"2026.02.04","stock":"-0.05","trade":null,"ind":"0.85"},{"date":"2026.02.03","stock":"-0.91","trade":null,"ind":"1.29"},{"date":"2026.02.02","stock":"-1.37","trade":null,"ind":"-2.48"},{"date":"2026.01.30","stock":"-0.62","trade":null,"ind":"-0.96"},{"date":"2026.01.29","stock":"0.37","trade":null,"ind":"0.16"},{"date":"2026.01.28","stock":"-2.54","trade":null,"ind":"0.27"},{"date":"2026.01.27","stock":"0.39","trade":null,"ind":"0.18"}]
佰仁医疗,上证指数,医疗器械指数
压力支撑
该股压力位为101.41元，支撑位为99.30元。
[{"text":"\u538b\u529b\u4f4d","value":"101.41","date":1772553600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"99.30","date":1772553600,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：5.7资金面打败了90%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：03月04日 17:24
| 机构今日流向(万元) | -537.06 | 机构5日流向(万元) | -5095.38 |
| 机构10日流向(万元) | -7254.05 | 机构20日流向(万元) | -15526.82 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少2781.67万股，其中基金净减仓2家，主力净减仓125家，请投资者中长期谨慎为宜。
截止2025-12-31，共10家主力机构（基金10家），持仓量总计276.38万股，占流通A股2.01%
其中，基金持仓与2025-06-30相比：
增仓：3家 ，增持 101.24万股
减仓：5家 ，减持 21.54万股
新出现在主力名单中：1家 ，持有2.39万股
从主力名单中消失：126家 ，原持有2863.76万股
其中，基金持仓与2025-06-30相比：
增仓：3家 ，增持 101.24万股
减仓：5家 ，减持 21.54万股
新出现在主力名单中：1家 ，持有2.39万股
从主力名单中消失：126家 ，原持有2863.76万股
消息面诊股
诊断结果：5消息面打败了72%的股票
今日有利好新闻的公司
近期该股消息很少，消息面信号较弱。
更多>>个股资讯
- 佰仁医疗：3月3日获融资买入507.26万元
2026-03-04 - 艾佰瑞学术交流会召开 业内专家共论注娇研临床突破
2026-03-03 - 佰仁医疗：3月2日获融资买入454.93万元
2026-03-03 - 佰仁医疗：2月27日获融资买入228.71万元
2026-02-28 - 佰仁医疗：2025年净利润2亿元，同比增长36.8
2026-02-27 - 佰仁医疗：2月26日获融资买入432.44万元
2026-02-27 - 佰仁医疗：2月25日获融资买入763.81万元
2026-02-26 - 佰仁医疗：2月24日获融资买入636.78万元
2026-02-25 - 佰仁医疗：2月13日获融资买入186.72万元
2026-02-14 - 佰仁医疗：2月12日获融资买入620.18万元
2026-02-13
消息列表
| 一般消息 | 高管变动 | 公司内部治理结构调整 | 2025-09-25 |
| 一般消息 | 高管变动 | 取消公司监事会 | 2025-09-16 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-28 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-28 |
| 利好 | 分红转增 | 10派8元(含税) | 2025-04-25 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了11%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2026.03.04","price":"-0.98","value":null},{"date":"2026.03.03","price":"-1.43","value":null},{"date":"2026.03.02","price":"0.47","value":null},{"date":"2026.02.27","price":"0.39","value":null},{"date":"2026.02.26","price":"-0.01","value":null},{"date":"2026.02.25","price":"0.72","value":null},{"date":"2026.02.24","price":"0.87","value":null},{"date":"2026.02.13","price":"-1.26","value":null},{"date":"2026.02.12","price":"0.05","value":null},{"date":"2026.02.11","price":"0.09","value":null},{"date":"2026.02.10","price":"0.13","value":null},{"date":"2026.02.09","price":"1.41","value":null},{"date":"2026.02.06","price":"-0.25","value":null},{"date":"2026.02.05","price":"-0.64","value":null},{"date":"2026.02.04","price":"0.85","value":null},{"date":"2026.02.03","price":"1.29","value":null},{"date":"2026.02.02","price":"-2.48","value":null},{"date":"2026.01.30","price":"-0.96","value":null},{"date":"2026.01.29","price":"0.16","value":null},{"date":"2026.01.28","price":"0.27","value":null},{"date":"2026.01.27","price":"0.18","value":"-357279036.44"}]
上证指数,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 爱迪特 | 49.09% | 8.58% | 5.8分 |
| 2 | 振德医疗 | 30.43% | 1.10% | 6.3分 |
| 3 | 九安医疗 | 15.94% | 13.54% | 5.6分 |
| 4 | 心脉医疗 | 12.46% | 5.82% | 6.0分 |
| 5 | 采纳股份 | 11.30% | 4.53% | 5.1分 |
| 6 | 华强科技 | 10.61% | 3.90% | 5.9分 |
| 8 | 奕瑞科技 | 4.40% | 2.17% | 5.5分 |
| 10 | 可孚医疗 | 4.04% | 3.89% | 5.4分 |
| 12 | 蓝帆医疗 | 1.48% | 2.65% | 5.5分 |
| 14 | 三鑫医疗 | 0.00% | 5.16% | 5.7分 |
| 16 | 康拓医疗 | -1.81% | -4.25% | 5.3分 |
| 18 | 天智航 | -1.97% | -6.58% | 4.5分 |
| 20 | 东方海洋 | -2.18% | -3.45% | 4.8分 |
| 22 | ST凯利 | -3.05% | -2.11% | 5.5分 |
| 24 | 戴维医疗 | -3.44% | -3.84% | 5.6分 |
| 26 | 迈普医学 | -4.42% | -7.66% | 4.9分 |
| 28 | 爱威科技 | -4.88% | -9.49% | 5.3分 |
| 30 | 东富龙 | -5.23% | -4.47% | 5.0分 |
| 32 | 维力医疗 | -5.68% | -7.70% | 5.3分 |
| 34 | 天益医疗 | -6.07% | -4.07% | 4.4分 |
| 36 | 正川股份 | -6.43% | -6.43% | 4.4分 |
| 38 | 东星医疗 | -6.89% | -8.42% | 3.5分 |
| 40 | 联影医疗 | -7.03% | -3.65% | 4.7分 |
| 42 | 康德莱 | -7.30% | -6.11% | 5.0分 |
| 44 | 爱博医疗 | -7.45% | -6.91% | 4.6分 |
| 46 | 奥泰生物 | -7.55% | -5.34% | 4.5分 |
| 48 | 微电生理 | -8.13% | -3.50% | 4.8分 |
| 50 | 普门科技 | -8.31% | -6.93% | 4.8分 |
| 52 | 理邦仪器 | -8.43% | -5.12% | 5.7分 |
| 54 | 迈瑞医疗 | -8.54% | -6.00% | 4.1分 |
| 56 | 山外山 | -8.72% | -7.97% | 6.0分 |
| 58 | 英诺特 | -8.96% | -7.43% | 4.4分 |
| 60 | 亚辉龙 | -9.03% | -0.66% | 4.1分 |
| 62 | 佰仁医疗 | -9.06% | -2.31% | 4.9分 |
| 64 | 睿昂基因 | -9.12% | -11.25% | 3.8分 |
| 66 | 安杰思 | -9.37% | -6.21% | 4.4分 |
| 68 | 健帆生物 | -9.61% | -6.36% | 4.1分 |
| 70 | 拱东医疗 | -9.83% | -7.26% | 4.6分 |
| 72 | 基蛋生物 | -9.92% | -6.52% | 4.6分 |
| 74 | 尚荣医疗 | -10.30% | -7.75% | 4.7分 |
| 76 | 迪瑞医疗 | -10.69% | -5.65% | 3.5分 |
| 78 | 明德生物 | -10.75% | -5.71% | 3.2分 |
| 80 | 南微医学 | -11.08% | -12.41% | 4.7分 |
| 82 | - | -11.30% | -7.14% | 分 |
| 84 | 健信超导 | -11.75% | -5.72% | 4.9分 |
| 86 | 奥精医疗 | -11.91% | -13.50% | 4.4分 |
| 88 | - | -11.99% | -2.14% | 分 |
| 90 | 中红医疗 | -12.14% | -7.43% | 4.0分 |
| 92 | 科美诊断 | -12.41% | -7.51% | 3.8分 |
| 94 | 大博医疗 | -12.52% | -5.81% | 3.8分 |
| 96 | 麦澜德 | -12.60% | -7.59% | 4.8分 |
| 98 | 超研股份 | -13.02% | -8.48% | 4.6分 |
| 100 | 凯普生物 | -13.24% | -8.18% | 4.0分 |
| 102 | 麦克奥迪 | -13.59% | -9.46% | 4.2分 |
| 104 | 九强生物 | -14.13% | -6.62% | 3.1分 |
| 106 | 美好医疗 | -14.45% | -15.28% | 4.2分 |
| 108 | 冠昊生物 | -15.37% | -8.72% | 4.6分 |
| 110 | 楚天科技 | -15.61% | -9.24% | 4.3分 |
| 112 | 东方生物 | -16.05% | -9.06% | 4.1分 |
| 114 | 祥生医疗 | -16.21% | -10.62% | 5.0分 |
| 116 | 易瑞生物 | -17.59% | -10.14% | 4.0分 |
| 118 | 透景生命 | -17.86% | -9.62% | 3.1分 |
| 120 | 利德曼 | -18.52% | -7.30% | 4.4分 |
| 122 | 赛诺医疗 | -19.26% | -9.89% | 4.5分 |
| 124 | 科华生物 | -19.61% | -8.36% | 3.6分 |
| 126 | 热景生物 | -20.72% | -9.42% | 3.0分 |
| 128 | 福瑞医科 | -21.32% | -16.21% | 4.8分 |
| 130 | 康众医疗 | -23.11% | 0.64% | 4.1分 |
| 132 | 万孚生物 | -25.20% | -6.09% | 3.5分 |
| 134 | 硕世生物 | -25.68% | -9.94% | 3.5分 |
| 136 | - | - | -0.79% | 分 |
| 138 | 北芯生命 | - | -7.49% | 4.5分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 29/243 ， 1/243。
[{"date":"2025-09-30","value":"7.42","vol":"2.98"},{"date":"2025-06-30","value":"5.78","vol":"2.34"},{"date":"2025-03-31","value":"2.56","vol":"1.16"},{"date":"2024-12-31","value":"11.96","vol":"0.56"},{"date":"2024-09-30","value":"4.96","vol":"4.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
7.42 | 5.78 | 2.56 | 11.96 | 4.96 |
| 行业(%) | 2.98 | 2.34 | 1.16 | 0.56 | 4.64 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"88.17","vol":"51.73"},{"date":"2025-06-30","value":"88.54","vol":"52.04"},{"date":"2025-03-31","value":"85.72","vol":"51.41"},{"date":"2024-12-31","value":"88.34","vol":"52.51"},{"date":"2024-09-30","value":"88.56","vol":"53.36"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
88.17 | 88.54 | 85.72 | 88.34 | 88.56 |
| 行业(%) | 51.73 | 52.04 | 51.41 | 52.51 | 53.36 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 9/243 ， 17/243。
[{"date":"2025-09-30","value":"30.58","vol":"0.24"},{"date":"2025-06-30","value":"30.07","vol":"-1.07"},{"date":"2025-03-31","value":"31.30","vol":"-0.10"},{"date":"2024-12-31","value":"35.41","vol":"1.15"},{"date":"2024-09-30","value":"13.57","vol":"0.77"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
30.58 | 30.07 | 31.30 | 35.41 | 13.57 |
| 行业(%) | 0.24 | -1.07 | -0.10 | 1.15 | 0.77 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"57.93","vol":"-15.37"},{"date":"2025-06-30","value":"102.90","vol":"-18.14"},{"date":"2025-03-31","value":"290.69","vol":"-2.59"},{"date":"2024-12-31","value":"27.02","vol":"-23.09"},{"date":"2024-09-30","value":"-16.56","vol":"-19.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
57.93 | 102.90 | 290.69 | 27.02 | -16.56 |
| 行业(%) | -15.37 | -18.14 | -2.59 | -23.09 | -19.92 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 58/243 ， 115/243。
[{"date":"2025-09-30","value":"0.26","vol":"0.25"},{"date":"2025-06-30","value":"0.17","vol":"0.17"},{"date":"2025-03-31","value":"0.07","vol":"0.08"},{"date":"2024-12-31","value":"0.36","vol":"0.36"},{"date":"2024-09-30","value":"0.22","vol":"0.26"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.26 | 0.17 | 0.07 | 0.36 | 0.22 |
| 行业(次) | 0.25 | 0.17 | 0.08 | 0.36 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.72","vol":"1.66"},{"date":"2025-06-30","value":"0.47","vol":"1.12"},{"date":"2025-03-31","value":"0.25","vol":"0.55"},{"date":"2024-12-31","value":"1.34","vol":"2.32"},{"date":"2024-09-30","value":"0.78","vol":"1.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.72 | 0.47 | 0.25 | 1.34 | 0.78 |
| 行业(次) | 1.66 | 1.12 | 0.55 | 2.32 | 1.64 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"18.40","vol":"14.75"},{"date":"2025-06-30","value":"44.56","vol":"15.16"},{"date":"2025-03-31","value":"9.36","vol":"4.21"},{"date":"2024-12-31","value":"55.91","vol":"29.34"},{"date":"2024-09-30","value":"8.52","vol":"15.46"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 18.40 | 44.56 | 9.36 | 55.91 | 8.52 |
| 行业 | 14.75 | 15.16 | 4.21 | 29.34 | 15.46 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"4.27","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"6.43","vol":"2.17"},{"date":"2024-09-30","value":"","vol":"0.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 4.27 | - | 6.43 | - |
| 行业 | 0.01 | 1.57 | 0.00 | 2.17 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 46/243 ， 47/243。
[{"date":"2025-09-30","value":"3.30","vol":"5.66"},{"date":"2025-06-30","value":"3.32","vol":"5.47"},{"date":"2025-03-31","value":"5.41","vol":"5.84"},{"date":"2024-12-31","value":"5.17","vol":"5.30"},{"date":"2024-09-30","value":"8.99","vol":"5.83"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
3.30 | 3.32 | 5.41 | 5.17 | 8.99 |
| 行业 | 5.66 | 5.47 | 5.84 | 5.30 | 5.83 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.39","vol":"4.51"},{"date":"2025-06-30","value":"1.79","vol":"4.35"},{"date":"2025-03-31","value":"3.32","vol":"4.73"},{"date":"2024-12-31","value":"3.26","vol":"4.27"},{"date":"2024-09-30","value":"5.53","vol":"4.70"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.39 | 1.79 | 3.32 | 3.26 | 5.53 |
| 行业 | 4.51 | 4.35 | 4.73 | 4.27 | 4.70 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 73/243 ， 74/243。
[{"date":"2025-09-30","value":"17.09","vol":"22.07"},{"date":"2025-06-30","value":"16.78","vol":"22.01"},{"date":"2025-03-31","value":"12.93","vol":"21.19"},{"date":"2024-12-31","value":"12.60","vol":"21.94"},{"date":"2024-09-30","value":"9.27","vol":"20.60"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
17.09 | 16.78 | 12.93 | 12.60 | 9.27 |
| 行业(%) | 22.07 | 22.01 | 21.19 | 21.94 | 20.60 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.20","vol":"0.71"},{"date":"2025-06-30","value":"0.20","vol":"0.58"},{"date":"2025-03-31","value":"0.15","vol":"0.56"},{"date":"2024-12-31","value":"0.14","vol":"0.55"},{"date":"2024-09-30","value":"0.10","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.20 | 0.20 | 0.15 | 0.14 | 0.10 |
| 行业(%) | 0.71 | 0.58 | 0.56 | 0.55 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"0.51","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.95","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.15","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.46","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"2.06","blueLineValue":"1.50","type":"YC"}]